Organogenesis Establishes $75M At-the-Market Equity Offering

Organogenesis Holdings Inc. has entered into an At-the-Market Sales Agreement with BTIG, LLC and Citizens JMP Securities, LLC. This agreement allows the company to offer and sell shares of its Class A common stock from time to time, with an aggregate offering price of up to $75,000,000. Sales will be conducted as "at the market offerings" on the Nasdaq Capital Market or other trading markets, and the agents will receive a commission of up to 3.0% of the gross sales price. The offering is made under a previously filed shelf registration statement.